Anionic mucoadhesive polymers as auxiliary agents for the peroral administration of (poly)peptide drugs:: Influence of the gastric juice

被引:21
作者
Bernkop-Schnürch, A [1 ]
Gilge, B [1 ]
机构
[1] Univ Vienna, Inst Pharmaceut Technol, Ctr Pharm, A-1090 Vienna, Austria
关键词
enteric coating; mucoadhesive polymers; pepsin; (poly) peptide drugs;
D O I
10.1081/DDC-100100335
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
The incorporation of (poly)peptide drugs in mucoadhesive polymers is a promising strategy for their peroral administration. In this study, the protective effect of various polymers toward an artificial gastric fluid and the influence of an enteric coating on the adhesive properties have been investigated. Tablets containing 30 mg of carbomer (C934P), neutralized carbomer (NaC934P), or sodium carboxymethylcellulose (NaCMC), 0.1 mg of the model protein peroxidase, and 19.9 mg of mannitol were incubated at 37 degrees C for 2.5 hr with a simulated gastric fluid with and without pepsin. All polymers-although anionogenic-displayed quick swelling behavior in the acid milieu, leading to an unintended protein release. Moreover, pepsin is capable of penetrating into the polymeric carrier systems, thereby rapidly degrading the embedded protein. Enteric coating, on the other hand, leads to strongly reduced adhesive properties. Only NaC934P tablets coated with polymethacrylate containing 9% triethylcitrate displayed no significant (p < .05) reduction in adhesive strength. Results give essential basic information for the development of peroral (poly)peptide dosage forms based on mucoadhesive polymers.
引用
收藏
页码:107 / 113
页数:7
相关论文
共 20 条
[1]
The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins [J].
Bernkop-Schnurch, A .
JOURNAL OF CONTROLLED RELEASE, 1998, 52 (1-2) :1-16
[2]
Basic studies on bioadhesive delivery systems for peptide and protein drugs [J].
Bernkop-Schnürch, A ;
Humenberger, C ;
Valenta, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 165 (02) :217-225
[3]
Synthesis and evaluation of a modified mucoadhesive polymer protecting from alpha-chymotrypsinic degradation [J].
BernkopSchnurch, A ;
Apprich, I .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 146 (02) :247-254
[4]
Modified mucoadhesive polymers for the peroral administration of mainly elastase degradable therapeutic (poly)peptides [J].
BernkopSchnurch, A ;
Schwarz, GH ;
Kratzel, M .
JOURNAL OF CONTROLLED RELEASE, 1997, 47 (02) :113-121
[5]
Novel bioadhesive drug delivery system protecting (poly)peptides from gastric enzymatic degradation [J].
BernkopSchnurch, A ;
Dundalek, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 138 (01) :75-83
[6]
Development and in vitro evaluation of a drug delivery system protecting from trypsinic degradation [J].
BernkopSchnurch, A ;
Bratengeyer, I ;
Valenta, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 157 (01) :17-25
[7]
Novel bioadhesive chitosan-EDTA conjugate protects leucine enkephalin from degradation by aminopeptidase N [J].
BernkopSchnurch, A ;
Paikl, C ;
Valenta, C .
PHARMACEUTICAL RESEARCH, 1997, 14 (07) :917-922
[8]
Development and analysis of a polymer protecting from luminal enzymatic degradation caused by alpha-chymotrypsin [J].
BernkopSchnurch, A ;
Gockel, NC .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (08) :733-740
[9]
STARCH MICROSPHERES INDUCE PULSATILE DELIVERY OF DRUGS AND PEPTIDES ACROSS THE EPITHELIAL BARRIER BY REVERSIBLE SEPARATION OF THE TIGHT JUNCTIONS [J].
BJORK, E ;
ISAKSSON, U ;
EDMAN, P ;
ARTURSSON, P .
JOURNAL OF DRUG TARGETING, 1995, 2 (06) :501-507
[10]
PHARMACEUTICAL AND MEDICAL ASPECTS OF BIOADHESIVE SYSTEMS FOR DRUG ADMINISTRATION [J].
DUCHENE, D ;
TOUCHARD, F ;
PEPPAS, NA .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1988, 14 (2-3) :283-318